newsfilter
← Latest News
PR Newswire·

MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent Application

VANCOUVER, BC, Dec. 15, 2021 /PRNewswire/ - MYND Life Sciences Inc. ("MYND" or the "Company") (CSE:MYND) (OTC:MYNDF) is pleased to announce it has completed the National Phase filing of its Patent Cooperation Treaty (PCT) patent application, following